Wednesday, December 17, 2014

Follow us:
Follow us on Facebook Follow us on Twitter Subscribe to this news feed 


This section displays the last 30 news articles that were published.

Can Drugs Already on the Market Slow Parkinson's Disease?

  • Text size: + -
Rochester: Can Drugs Already on the Market Slow Parkinson's Disease?
Play now

Time Warner Cable video customers:
Sign in with your TWC ID to access our video clips.

  To view our videos, you need to
enable JavaScript. Learn how.
install Adobe Flash 9 or above. Install now.

Then come back here and refresh the page.

When it comes to living with Parkinson's Disease. Gary Hilburger knows what others are going through.

That's why he was excited to hear of a new study involving researchers at the University of Rochester – a clinical trial to evaluate whether an old drug used to treat high blood pressure might provide new hope for Parkinson's patients.

"Identifying a drug that slows progression is really the holy grail of treatment. There are currently no treatments that have been identified to do that," said Dr. Kevin Biglan, one of the study's leaders.

"I've been in four trials so far, and I'll continue to do so until there's no breath left in my body," Gary said. "What keeps me going in all this, is it's not about me. That's the whole deal."

The three-year trial is made possible thanks to a $23 million grant from the National Institutes of Health. ClientIP:, UserAgent: CCBot/2.0 ( Profile: TWCSAMLSP